Both Novo Nordisk and Eli Lilly are studying their weight loss drugs to treat fatty liver disease, chronic kidney disease, ...
International media reports have said hospitals are being 'overwhelmed' by cases, but medical staff say that is not the case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback